Stocks and Investing Stocks and Investing
Mon, January 23, 2023

Jonathan Yong Maintained (AMED) at Buy with Decreased Target to $115 on, Jan 23rd, 2023


Published on 2024-10-28 01:02:55 - WOPRAI, Jonathan Yong
  Print publication without navigation


Jonathan Yong of Credit Suisse, Maintained "Amedisys, Inc." (AMED) at Buy with Decreased Target from $140 to $115 on, Jan 23rd, 2023.

Jonathan has made no other calls on AMED in the last 4 months.



There are 10 other peers that have a rating on AMED. Out of the 10 peers that are also analyzing AMED, 3 agree with Jonathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Whit Mayo of "SVB Leerink" Maintained at Hold with Decreased Target to $85 on, Thursday, January 5th, 2023
  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $106 on, Friday, November 11th, 2022
  • John Ransom of "Raymond James" Downgraded from Buy to Hold on, Thursday, October 27th, 2022


These are the ratings of the 7 analyists that currently disagree with Jonathan


  • Colin Rusch of "Oppenheimer" Maintained at Buy with Decreased Target to $125 on, Thursday, January 19th, 2023
  • Frank Morgan of "RBC Capital" Maintained at Buy with Decreased Target to $139 on, Monday, October 31st, 2022
  • David Macdonald of "Truist Securities" Maintained at Strong Buy with Decreased Target to $130 on, Friday, October 28th, 2022
  • Michael Wiederhorn of "Oppenheimer" Maintained at Buy with Decreased Target to $145 on, Friday, October 28th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $126 on, Friday, October 28th, 2022
  • Justin Bowers of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $165 on, Monday, October 24th, 2022
  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $135 on, Monday, October 3rd, 2022

Contributing Sources